Long term consequences of arsenical treatment for multiple sclerosis.
D000328:Adult; D001151:Arsenic / Q000009:adverse effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects*; D002295:Carcinoma, Transitional Cell / Q000139:chemically induced*; D006801:Humans; D006975:Hypertension, Portal / Q000139:chemically induced*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D010087:Oxides; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
D001152:Arsenicals; D010087:Oxides; D001151:Arsenic; D000077237:Arsenic Trioxide